While different types of progressive familial intrahepatic cholestasis (PFIC) vary in their genetic cause and clinical profile, new medications like Bylvay (odevixibat) and Livmarli (maralixibat) have shown promise across several PFIC types, including rare ones, in children. That’s according to a review study, titled “New hope in treating progressive familial intrahepatic cholestasis in children,” which […] The post New medications show promise for children with rare liver disease app...| Liver Disease News – The Web's Daily Resource for Liver Disease News
Pediatrician discusses the importance of early check-ups with your newborn to monitor jaundice, weight gain, and even diaper rash.| Healthier, Happy Lives Blog
Does the method of admission affect care for patients with neonatal hyperbilirubinemia?| Pediatrics Nationwide
The low amount of bacteria from the gut microbiota able to process bilirubin, a product of heme degradation, during the neonatal period of life suggests a strong connection between the microbiome composition and development of jaundice in infants. In other words, the lack of certain bacteria in the gut of infants seems to be linked to the risk of developing jaundice.| Gut Microbiota for Health